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Mammalian Staufen1 Recruits Upf1 to Specific
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2003; Ohashi et al., 2002) as well as its encapsidationCanada
together with HIV-1 RNA in virus particles (Mouland et
al., 2000). Additionally, Stau1 interacts with telomerase
RNA, suggesting that it functions during DNA replica-Summary
tion, cell division, or both, possibly by influencing tel-
omerase RNA processing, RNP assembly, or localizationMammalian Staufen (Stau)1 is an RNA binding protein
(Bachand et al., 2001; Le et al., 2000).that is thought to function in mRNA transport and
In this study, we add Stau1 to the repertoire of proteinstranslational control. Nonsense-mediated mRNA de-
that are involved in mRNA decay. Furthermore, we dem-cay (NMD) degradesabnormal andnaturalmRNAs that
onstrate that Stau1-mediated mRNA decay (SMD) in-terminate translation sufficiently upstream of a splic-
volves the nonsense-mediated mRNA decay (NMD)ing-generated exon-exon junction. Here we describe
factor Upf1. NMD in mammalian cells is generally a splic-an mRNA decay mechanism that involves Stau1, the
ing-dependent mechanism that degrades newly synthe-NMD factor Upf1, and a termination codon. Unlike
sized mRNAs that prematurely terminate translation (re-NMD, this mechanism does not involve pre-mRNA
viewed in Hentze and Kulozik [1999], Maquat [2004a,splicing and occurs when Upf2 or Upf3X is downregu-
2004b], Wilusz et al. [2001]). By so doing, NMD precludeslated. Stau1 binds directly to Upf1 and elicits mRNA
the synthesis of the encoded truncated proteins, whichdecay when tethered downstream of a termination
can function in deleterious ways (see, e.g., Inoue et al.codon. Stau1 also interacts with the 3-untranslated
[2004]). NMD also targets naturally occurring mRNAsregion of ADP-ribosylation factor (Arf)1 mRNA. Ac-
such as certain selenoprotein mRNAs and an estimatedcordingly, downregulating either Stau1 or Upf1 in-
one-third of alternatively spliced mRNAs, some of whichcreases Arf1 mRNA stability. These findings suggest
encode functional protein isoforms (Hillman et al., 2004;that Arf1 mRNA is a natural target for Stau1-mediated
Mendell et al., 2004).decay, and data indicate that other mRNAs are also
The dependence of NMD on splicing reflects the de-natural targets. We discuss this pathway as a means
position of an exon junction complex (EJC) of proteinsfor cells to downregulate the expression of Stau1 bind-
20–24 nucleotides upstream of splicing-generateding transcripts.
exon-exon junctions (Kataoka et al., 2000; Kim et al.,
2001; Le Hir et al., 2000a, 2000b; Lykke-Andersen et al.,Introduction
2001). This EJC includes NMD factors Upf3 (also called
Upf3a) or Upf3X (also called Upf3b), Upf2, and possibly
Mammalian Staufen (Stau)1 is an RNA binding protein
Upf1 (Gehring et al., 2003; Kim et al., 2001; Lejeune et
that binds to extensive RNA secondary structures, pri- al., 2002; Lykke-Andersen et al., 2000, 2001). Upf3 and
marily through one or more double-stranded RNA bind- Upf3X appear to play a comparable role in NMD (Kim
ing domains (Marion et al., 1999; Wickham et al., 1999). et al., 2001; Lykke-Andersen et al., 2001), although differ-
The role of Staufen is best characterized in Drosophila, ent isoforms of Upf3 can form distinct protein complexes
where it functions in the transport and localization of (Ohnishi et al. [2003]; Upf3X was not studied). Other
bicoid and oskar mRNAs to, respectively, the anterior constituents of the EJC include Y14, RNPS1, SRm160,
and posterior poles of oocytes, and prospero mRNA REF/Aly, UAP56, Magoh, Pnn/DRS, eIF4AIII, Barentsz,
during asymmetric divisions of embryonic neuroblasts and possibly PYM (Bono et al., 2004; Chan et al., 2004;
(Broadus et al., 1998; Li et al., 1997; Matsuzaki et al., Degot et al., 2004; Ferraiuolo et al., 2004; Kataoka et
1998; Schuldt et al., 1998; Shen et al., 1998; St Johnston, al., 2000; Kim et al., 2001; Le Hir et al., 2000b, 2001;
1995). Drosophila Staufen also functions in the transla- Lejeune et al., 2002; Li et al., 2003; Luo et al., 2001;
tional derepression of oskar mRNA once the mRNA has Palacios et al., 2004; Shibuya et al., 2004). EJCs are
been localized to the posterior pole (Ephrussi et al., present on mRNA that is bound at the cap by the major
1991; Kim-Ha et al., 1991, 1995; Micklem et al., 2000). nuclear cap binding protein (CBP)80-CBP20 hetero-
In mammals, the Stau1 gene is ubiquitously expressed dimer, which is consistent with data indicating that NMD
and generates protein isoforms having apparent molec- targets CBP80 bound mRNA as a consequence of a
pioneer round of translation (Chiu et al., 2004; Ishigaki
et al., 2001; Lejeune et al., 2002, 2004).*Correspondence: lynne_maquat@urmc.rochester.edu
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Figure 1. Human Upf1 Interacts with Human Staufen (Stau)1
(A) Yeast two-hybrid screening. Human Upf1 as bait interacts with human Stau1 from the pMyr-cDNA library (upper). Negative and positive
controls were provided by Stratagene. The region of Stau1 that interacts with Upf1 was mapped to reside within the double-stranded RNA
binding domain (dsRBD)4 and tubulin binding domain (TBD) (lower).
(B) GST pull-down assays. E. coli lysates that expressed GST-Upf1 () were mixed with E. coli lysates that did not () or did () express
6xHis-Stau1, purified using glutathione-Sepharose beads (After) or not (Before), and subjected to Western blotting (WB) using -GST antibody
(upper) or -His antibody (middle). Additionally, a fraction of each sample was analyzed by Coomassie blue staining to verify the presence
of GST-Upf1 and 6xHis-Stau1 (lower, indicated by dots).
(C) Far Western analysis. E. coli lysates that did not () or did () produce either 6xHis-Stau1 or GST-Stau1 were subjected to Far Western
blotting (FW) using FLAG-Upf1 that had been immunopurified from HeLa cells (middle) or GST-Upf1 that had been immunopurified from E. coli
(right). Interacting proteins were identified by Western blotting using -FLAG or -GST antibody, respectively. Expression of 6xHis-Stau1 and
GST-Stau1 was also verified by staining each lysate with Coomassie blue (left).
(D) IP of Stau1-HA3. Cos cells were transiently transfected with a plasmid that expressed the 55 kDa isoform of Stau1-HA3. After cell lysis,
RNA and protein were purified from the lysate before and after IP using -HA antibody or, to control for the specificity of the IP, rat (r) IgG.
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Here we show that mammalian Stau1 binds the NMD ure 1C, right). Coomassie blue staining confirmed the
presence of 6xHis-Stau1 and GST-Stau1 (Figure 1C,factor Upf1 and the 3-untranslated region (UTR) of
mRNA that encodes ADP-ribosylation factor (Arf)1. As left).
Third, Stau1-HA3 that had been immunopurified froma result, Stau1 mediates Arf1 mRNA decay by a mecha-
nism that differs from NMD because it occurs indepen- Cos cells using -HA antibody copurified with cellular
Upf1 in a manner that was resistant to the addition ofdently of splicing and after downregulating Upf2 or
Upf3X but not after downregulating Stau1. Analogously RNase A prior to immunopurification (IP) (Figure 1D,
upper). This suggests that the interaction of Stau1 andto the SMD of Arf1 mRNA, artificially tethering Stau1
downstream of a normal termination codon also reduces Upf1 is stable in the absence of RNA. RNase A treatment
was effective, as demonstrated by the disappearancemRNA abundance by a mechanism that depends on the
normal termination codon and Upf1 but does not require of cellular SMG7 mRNA in samples that were analyzed
before IP (Figure 1D, lower). Stau1-HA3 also coimmuno-splicing and is unaffected when Upf2 or Upf3X is down-
regulated. Microarray analyses have identified a number purified with Barentsz and CBP80, although in an RNase
A-sensitive manner, but did not coimmunopurify withof transcripts in addition to Arf1 mRNA that bind Stau1
and therefore may also be regulated by SMD. eIF4E or a nonspecific control, vimentin, which is a com-
ponent of intermediate filaments (Figure 1D, upper). The
coimmunoprecipitation (CoIP) of Stau1 with Barentsz
Results had previously been shown to be RNase A sensitive
(Macchi et al., 2003). Since Barentsz has been shown
Human Upf1 Interacts with Human Staufen1 to be essential for EJC-dependent NMD and a compo-
Using yeast two-hybrid analysis to screen a HeLa cell nent of the EJC (Degot et al., 2004; Palacios et al., 2004),
cDNA library for encoded proteins that interact with full- and since CBP80 and the EJC comprise the pioneer
length human Upf1, human Stau1 was identified in four translation initiation complex (Chiu et al., 2004; Ishigaki
out of one million transformants on the basis of growth at et al., 2001; Lejeune et al., 2002), Stau1 also likely com-
37C in galactose-containing medium but not glucose- prises this complex. While antibodies to EJC compo-
containing medium (Figure 1A, upper). Galactose pro- nents Upf3 and Upf3X immunopurified the EJC compo-
moted transcription of cDNAs in the library, and the nent Upf2, they failed to immunopurify Stau1 (Figure
interaction of cDNA-encoded protein with Upf1 allowed 1E). These results suggest that (1) the interaction of
for growth at 37C. Sequence analysis of partial cDNAs Stau1 with the EJC was destabilized by the experimental
that were obtained in the screen indicated that Upf1 conditions; (2) Stau1 only transiently interacts with the
interacts with Stau1 within the fourth double-stranded EJC, as appears to be the case for Upf1 (Ishigaki et al.,
RNA binding domain, the tubulin binding domain, or 2001); or (3) Stau1 is not a component of the EJC. It is
both (Figure 1A, lower). unclear why -Upf3/3X antibody failed to immmunopur-
The ability of Upf1 to interact directly with Stau1 was ify Barentsz (Figure 1E).
confirmed using copurification assays. First, GST-Upf1 Fourth, FLAG-Upf1 that had been isolated from HeLa
that had been produced in E. coli interacted with 6xHis- cells using -FLAG antibody that was covalently conju-
Stau1 that had also been produced in E. coli. This was gated to an agarose affinity gel (Pal et al., 2001) copuri-
evident using GST pull-down to isolate GST-Upf1 (Figure fied with both the 55 kDa and 63 kDa isoforms of Stau1
1B, upper) followed by either Western blotting using as well as Upf2 and Upf3X but not Vimentin (Figure
-His antibody (Figure 1B, middle) or Coomassie blue 1F). These data also indicate that Stau1 and Upf1 are
staining (Figure 1B, lower) to confirm the presence of components of the same complex.
6xHis-Stau1. Notably, 6xHis-Stau1 was not detected in
the GST pull-down in the absence of GST-Upf1 (data
not shown). Downregulating Cellular Stau1 Has No Detectable
Consequence to the EJC-Dependent NMDSecond, FLAG-Upf1 that had been purified from HeLa
cells as well as GST-Upf1 that had been purified from of Gl or GPx1 mRNA
To gain insight into the possibility that Stau1 functionsE. coli were shown by Far Western analysis to interact
with 6xHis-Stau1 or GST-Stau1 that had been produced in EJC-dependent NMD, the effect of downregulating
the level of cellular Stau1 on the NMD of mRNAs forin E. coli. To this end, each tagged Stau1 protein was
electrophoresed in SDS-polyacrylamide and probed -globin (Gl) and glutathione peroxidase (GPx)1 was ex-
amined using small interfering RNAs (siRNAs). As a con-with either FLAG-Upf1 followed by Western blotting us-
ing -FLAG antibody (Figure 1C, middle) or GST-Upf1 trol, Upf3X was downregulated in parallel. HeLa cells
were transfected with Stau1 siRNA, Upf3X siRNA, or afollowed by Western blotting using -GST antibody (Fig-
RNase A was added to half of each sample prior to IP. SMG7 mRNA was analyzed using RT-PCR to demonstrate that the RNase A digestion
was complete (lower). The four leftmost lanes represent 2-fold serial dilutions of RNA and demonstrate that the RT-PCR is semiquantitative.
Western blotting was used to detect the specified proteins (upper). The three leftmost lanes represent 3-fold serial dilutions of protein before
IP and demonstrate that the Western blotting is semiquantitative.
(E) IP of cellular Upf3/3X. Lysate from untransfected Cos cells was immunopurified using -Upf3/3X antibody or, as a control for nonspecific
IP, normal rabbit serum (NRS). Western blotting was used to analyze the specified proteins. Upf3 comigrated with Ig heavy chains and thus
could not be analyzed.
(F) IP of FLAG-Upf1. Lysates of HeLa cells that did ( pCI-neo-FLAG-UPF1) or did not ( pCI-neo-FLAG-UPF1) stably express FLAG-Upf1
were analyzed either before or after IP using -FLAG antibody by Western blotting for the specified proteins.
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Figure 2. Downregulating Cellular Stau1 Has No Detectable Effect on EJC-Dependent NMD
HeLa cells were transiently transfected with Stau1 siRNA, Upf3X siRNA, or a nonspecific control siRNA. Two days later, cells were retransfected
with pmCMV-Gl and pmCMV-GPx1 test plasmids, either nonsense-free (Norm) or nonsense-containing (Ter), and the phCMV-MUP reference
plasmid. After an additional day, protein and RNA were purified.
(A) Western blot analysis of the siRNA-mediated downregulation of Stau1 or Upf3X, where the level of eIF3b served to control for variations
in protein loading.
(B) RT-PCR analysis of the level of Gl mRNA (left) or GPx1 mRNA (right), which was normalized to the level of MUP mRNA. Normalized levels
of Norm mRNA in the presence of each siRNA were defined as 100%. Levels in three independently performed experiments did not vary by
more than 7%.
nonspecific “control” siRNA and, 2 days later, with three when tethered to a series of MS2 coat protein binding
sites that were located more than 50 nt downstreamplasmids: (1) the pmCMV-Gl test plasmid that was either
nonsense free (Norm) or nonsense containing (39Ter); of a normal termination codon (Lykke-Andersen et al.,
2000). Since the reduced mRNA abundance was depen-(2) the pmCMV-GPx1 test plasmid, either Norm or 46Ter;
and (3) the phCMV-MUP reference plasmid. dent on the normal termination codon, it was attributed
to NMD. This or similar tethering methods have subse-The level of each Stau1 isoform was downregulated
to 28% of normal, where normal is defined as the level quently been used to provide evidence that Y14, RNPS1,
PYM, and Barentsz also function in NMD (Bono et al.,in the presence of the nonspecific control siRNA, and
the level of Upf3X was downregulated to 24% of normal 2004; Gehring et al., 2003; Lykke-Andersen et al., 2001;
Palacios et al., 2004).(Figure 2A). Using the level of Gl 39Ter or GPx1 46Ter
mRNA as a measure of NMD, downregulating Stau1 was Tethered Stau1 was similarly tested for the ability to
reduce mRNA abundance depending on an upstreamof no detectable consequence to the NMD of either
mRNA, whereas downregulating Upf3X abrogated NMD termination codon. HeLa cells were transiently trans-
fected with three plasmids: (1) a pcFLuc test plasmid5-fold or 3-fold, respectively (Figure 2B). Therefore,
Stau1 does not detectably function in the EJC-depen- that produces Firefly (F) luciferase (Luc) from intronless
FLuc cDNA that either does or does not harbor eightdent NMD of nonsense-containing Gl or GPx1 mRNA,
which is consistent with our failure to detect Stau1 as MS2 coat protein binding sites (MS2bs) within the 3UTR
(Figure 3A); (2) the pRLuc reference plasmid that pro-a stable component of the EJC (Figure 1).
duces Renilla (R)Luc (Figure 3A); and (3) a pMS2-HA
or pMS2-HA-Stau1 effector plasmid that, respectively,Tethered Stau1 Reduces mRNA Abundance
by a Mechanism that Involves Upf1 harbors no insert so as to encode only MS2 coat protein
(MS2)-HA or HA-Stau1 cDNA so as to encode a MS2-and an Upstream Termination Codon
In theory, Stau1 could elicit a type of EJC-independent HA-Stau1 fusion protein.
Cells that had been transfected with pMS2-HA ormRNA decay based on our finding that it binds to Upf1
and given that it is known to bind RNA. Previously, fu- pMS2-HA-Stau1 produced the expected fusion protein,
as evidenced by Western blotting using -HA antibodysions of each Upf protein and the bacteriophage MS2
coat protein were shown to reduce mRNA abundance (Figure 3B, left). As demonstrated using RT-PCR, while
Stau1-Mediated mRNA Decay
199
Figure 3. Tethering Stau1 to the FLuc mRNA 3UTR Reduces FLuc mRNA Abundance
(A) Schematic representations of pcFLuc-MS2bs, pcFLuc, and pRLuc, where X8 specifies eight tandem repeats of the MS2 coat protein
binding site.
(B) HeLa cells were cotransfected with pcFLuc-MS2bs or pcFLuc, pRLuc, and the specified effector plasmid. Two days after transfection,
protein and RNA were purified. Western blotting using -HA antibody demonstrates effector expression (left). RT-PCR demonstrates that
tethered Stau1 reduces FLuc-MS2bs mRNA abundance (right). Each normalized level of FLuc or FLuc-MS2bs mRNA was calculated as a
percentage of the normalized level of FLuc or FLuc-MS2bs mRNA that was obtained in the presence of pMS2-HA or pcNMS2, which was
defined as 100%. RT-PCR results of at least three independently performed experiments did not vary by more than 9%.
neither MS2-HA nor MS2-HA-Stau1 affected the level sisted of the pmCMV-Gl test plasmid, either Norm or
39Ter, and the phCMV-MUP reference plasmid. Theof FLuc mRNA that lacked the MS2bs, MS2-HA-Stau1
elicited a 3- to 4-fold reduction in the level of FLuc mRNA other combination consisted of the pcFLuc-MS2bs test
plasmid, the pRLuc reference plasmid, and an effectorthat harbored the MS2bs (Figure 3B, right). In control
experiments that were performed in parallel, MS2-Upf1 plasmid that produces MS2-HA, MS2-HA-Stau1, MS2,
MS2-Upf1, MS2-Upf2, or MS2-Upf3.and MS2-Upf2 (Lykke-Andersen et al., 2000) were also
of no consequence to the level of FLuc mRNA that Using Western blotting and the appropriate -Upf an-
tibody, the level of Upf1 or Upf3X (Figure 4A, left) orlacked the MS2bs but elicited a 2- to 5-fold reduction
in the level of FLuc mRNA that harbored the MS2bs Upf2 (Figure 4B, left) was shown to be downregulated,
respectively, to 4%, 28%, or 13% of normal. In control(Figure 3B, right). Furthermore, tethering an unrelated
protein, MS2-HA-eIF4AIII, or expressing Stau-HA3 or experiments, downregulating each protein abrogated
the NMD of Gl 39Ter mRNA 3- to 5-fold (Figures 4A andmyc-Upf1 that could not be tethered failed to affect the
abundance of FLuc-MS2bs mRNA (see Supplemental 4B, middle), as expected. Downregulating Upf1 but not
Upf3X abrogated the decrease in the abundance ofFigure S1 at http://www.cell.com/cgi/content/full/120/
2/195/DC1/). FLuc-MS2bs mRNA that was mediated by tethered Upf2
(Figure 4A, right). Furthermore, downregulating Upf2 ab-These data are consistent with the possibility that
tethering Stau1 downstream of a normal termination rogated the decrease in the abundance of FLuc-MS2bs
mRNA that was mediated by tethered Upf3 but had nocodon elicits mRNA decay. This possibility was exam-
ined in two ways. First, the effects of downregulating effect on the decrease that was mediated by tethered
Upf1 (Figure 4B, right). We conclude that Upf2 functionsthe level of cellular Upf1, Upf2, or Upf3X on the Stau1-
mediated reduction of FLuc-MS2bs mRNA abundance in NMD after Upf3 or Upf3X but before Upf1. Addition-
ally, downregulating Upf1 but not Upf3X or Upf2 abro-was examined. To this end, HeLa cells were transiently
transfected with the appropriate siRNA and, 2 days later, gated the decrease in the abundance of FLuc-MS2bs
mRNA that was mediated by tethered Stau1 (Figureswith a combination of plasmids. One combination con-
Cell
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Figure 4. siRNA-Mediated Downregulation of Cellular Upf1 but Not Upf2 or Upf3X Inhibits the Reduction in FLuc-MS2bs mRNA Abundance
that Is Mediated by Tethered Stau1
(A–C) HeLa cells were transiently transfected with the specified siRNA. Two days later, cells were transfected with pcFLuc-MS2bs, pRLuc,
and the specified effector plasmid. Alternatively, cells were transfected with a pmCMV-Gl test plasmid (either Norm or Ter) and the phCMV-
MUP reference plasmid. After an additional 2 days, protein and RNA were purified. Western blotting was used to quantitate the extent of
downregulation (left). RT-PCR was used to quantitate the effects of siRNA on Gl mRNA abundance (middle), as in Figure 2B, or FLuc-MS2bs
mRNA abundance after tethering the specified protein (right), as in Figure 3B. For all RT-PCR results, mRNA levels in at least two independently
performed experiments did not differ by more than 10%.
4A and 4B, right). We conclude that (1) Upf1 functions In related experiments, the effect of downregulating
the level of cellular Stau1 or, as a control, cellular Upf1downstream of Stau1 in the Stau1-mediated reduction
in mRNA abundance, and (2) Stau1 reduces mRNA on NMD that was elicited by tethering Upf1, Upf2, or
Upf3 to FLuc mRNA was determined. The level of eachabundance by a mechanism that does not appear to
involve Upf2 or Upf3X. These results make sense, given Stau1 isoform was downregulated to 29% of normal,
and the level of Upf1 was downregulated to 7% of nor-that Stau1 binds Upf1 (Figure 1) and that Upf1 is the
last of the Upf proteins to function in EJC-dependent mal (Figure 4C, left). According to expectations, down-
regulating Upf1 abrogated NMD that was elicited byNMD (Lykke-Andersen et al., 2000).
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tethering either Upf2 or Upf3 (Figure 4C, right). In con- The results of Western blotting demonstrated that the
level of each Stau1 isoform was downregulated to 26%trast, however, downregulating Stau1 had no effect on
of normal, and the level of Upf1, Upf2, or Upf3X wasNMD that was elicited by tethering Upf1, Upf2, or Upf3
downregulated to, respectively, 21%, 22%, or 13% of(Figure 4C, right). These results are consistent with our
normal (Figure 5B, upper). The results of RT-PCR usingfinding that Stau1 does not detectably affect EJC-
RNA from the same cells demonstrated that the abun-dependent NMD (Figure 2).
dance of endogenous HeLa cell Arf1 mRNA relative toMoving the translation termination codon from a posi-
the abundance of SMG7 mRNA as well as the abun-tion that resides upstream of the MS2 binding sites to
dance of Arf1 mRNA that derived from Arf1 cDNA relativea position that resides downstream of the sites was
to MUP mRNA was increased 2- to 4-fold in the presencefound to inhibit the Stau1-mediated reduction of either
of Stau1 or Upf1 siRNA relative to control siRNA (FigureFLuc-MS2bs or Gl-MS2bs mRNA abundance (see Sup-
5B, middle and lower; see also Supplemental Figure S4plemental Figure S2 on the Cell web site). While we
for comparable results using a different Stau1 or Upf1cannot discount the possibility that inhibition is due to
siRNA). In contrast, and as expected from the Stau1Stau1 removal by translating ribosomes, this result is
tethering results (Figures 3 and 4), the abundance ofconsistent with the possibility that Stau1 reduces mRNA
Arf1 mRNA from the gene or cDNA was unaffected byabundance by recruiting Upf1 to a position that resides
downregulating Upf3X (Figure 5B, middle and lower).downstream of a termination (i.e., nonsense) codon
For reasons that are not entirely clear, the abundance(see below).
of Arf1 mRNA was decreased by downregulating Upf2
(Figure 5B, middle and lower). Nevertheless, these dataStau1 Binds the 3UTR of Arf1 mRNA and Reduces
suggest that Stau1 reduces the abundance of Arf1Arf1 mRNA Abundance Independently of an EJC
mRNA by a mechanism that involves Upf1 but not Upf2In search of substrates that could be natural targets of
or Upf3X.Stau1-mediated effects, ADP-ribosylation factor (Arf)1
These findings also suggest that Stau1 binds Arf1mRNA, which encodes a Ras-related G protein that reg-
mRNA at a position that is located within the 3UTR.ulates membrane traffic and organelle structure (Don-
Consistent with this, deletion of the 3UTR increasedaldson and Jackson, 2000), was identified as a natural
the level of Arf1 mRNA 7-fold (Figure 5C). Moreover, in
ligand of Stau1 using two methods. First, using -HA
contrast to Arf1 mRNA, the abundance of Arf1(3UTR)
antibody, Stau1-containing RNPs were immunopurifed mRNA was unaffected by Stau1 siRNA relative to control
from human 293 cells that transiently expressed Stau1- siRNA (Figure 5C).
HA3 but were not immunopurified from 293 cells that In order to test for Stau1 binding to the 3UTR of Arf1
transiently expressed Stau1-6xHis, which served to con- mRNA, Cos cells were transiently transfected with
trol for IP specificity (Supplemental Figure S3A). When the Stau1-HA3 expression vector, the pSport-Arf1 or
biotin-labeled cRNAs were generated from the constit- pSport-Arf1(3UTR) test plasmid, and the phCMV-MUP
uent RNAs and used to probe oligonucleotide arrays of reference plasmid. Notably, cells were transfected with
22,000 human genes, Arf1 mRNA was identified as one only half as much pSport-Arf1(3UTR) as pSport-Arf1
of at least 23 ligands of Stau1 (Supplemental Figure in order to compensate for the difference in the level of
S3B; Supplemental Table S1). Second, using RT-PCR, product mRNA. Cell extract was prepared 2 days later,
Arf1 mRNA was shown to be among the 293 cell tran- and a fraction was immunopurified using -HA antibody
scripts that coimmunopurified with (1) -HA antibody in or, as a control for nonspecific IP, rat (r) IgG. Western
cells that expressed Stau1-HA3 (Supplemental Figure blotting of immunopurified protein demonstrated that
S3C) and (2)-Stau1 antibody in untransfected cells (Sup- the efficiency of IP was 11% (Figure 5D, upper). RT-PCR
plemental Figure S3C). of immunopurified RNA demonstrated the presence of
We rationalized that, if Stau1 binds to Arf1 mRNA at Arf1 mRNA, a low level of Arf1(3UTR) mRNA, and no
a position that reduces mRNA abundance, then down- detectable MUP mRNA (Figure 5D, lower). We conclude
regulating either Stau1 or Upf1 should upregulate the that Stau1 binds to the 3UTR of Arf1 mRNA, as was
level of Arf1 mRNA. Furthermore, downregulating either predicted from data demonstrating that Arf1 mRNA but
Stau1 or Upf1 should fail to upregulate the level of Arf1 not Arf1(3UTR) mRNA is naturally targeted for a Stau1-
mRNA that lacks the Stau1 binding site. To test these mediated reduction in abundance. Additionally, we con-
possibilities, HeLa cells were transiently transfected clude that Stau1 also binds elsewhere within Arf1 mRNA,
with control siRNA or siRNA that downregulates Stau1, albeit to a lesser extent. Consistent with this conclusion,
Upf1, Upf2, or Upf3X. Two days later, cells were tran- and in support of the idea that a termination codon must
siently transfected with two plasmids in order to mea- reside upstream of a Stau1 binding site in order for Stau1
sure effects on the abundance of Arf1 mRNA that was to mediate a reduction in mRNA abundance (Supple-
transiently produced from Arf1 cDNA. These plasmids mental Figure S2), the level of Arf1 mRNA that derived
consisted of (1) a pSport-Arf1 or pSport-Arf1(3UTR) from cDNA harboring a premature termination codon at
test plasmid, the latter of which lacks all nucleotides position 35 was upregulated 2-fold when Stau1 was
that reside downstream of the normal termination codon downregulated (data not shown). Notably, the specificity
(Figure 5A), and (2) the phCMV-MUP reference plasmid. of Stau1 binding to Arf1 mRNA was illustrated by the
Notably, the HeLa cell Arf1 gene contains four introns failure of Stau1 to bind to MUP mRNA (Figure 5D).
(Lee et al., 1992) so that the resulting newly synthesized
mRNA harbors four EJCs. In contrast, Arf1 cDNA within A Stau1 Binding Site Within the 3UTR of Arf1
either pSport plasmid lacks all introns so that the re- mRNA Elicits Arf1 mRNA Decay
sulting newly synthesized mRNA lacks EJCs and thus by a Upf1-Dependent Mechanism
provides an assay for the dependence of any Stau1- To further localize the Stau1 binding site within the Arf1
3UTR, a series of deletions was generated from themediated effect on an EJC.
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Figure 5. Stau1 Binds the 3UTR of Arf1 mRNA and Reduces Arf1 mRNA Abundance by a Mechanism that Involves Upf1
(A) Schematic representations of the Arf1 gene and the pSport-Arf1 and pSport-Arf1(3UTR) cDNA expression plasmids.
(B) As in Figure 4A, except that HeLa cells were transiently transfected with the specified siRNA. Two days later, cells were retransfected
with a pSport-Arf1 test plasmid and the reference phCMV-MUP plasmid. The efficiency of siRNA-mediated downregulation of gene expression
was assessed using Western blotting (upper). The levels of endogenous Arf1 and SMG7 mRNAs (middle) or of Arf1 mRNA that derived from
pSport-Arf1 and MUP mRNA (lower) were assessed using RT-PCR. Numbers below the panel represent the level of Arf1 mRNA after normalization
to the level of either SMG7 or MUP mRNA, where the normalized level of Arf1 mRNA in the presence of control siRNA was defined as 100%.
(C) As in (B), except that pSport Arf1 or pSport-Arf1(3UTR) was used as test plasmid.
(D) IP of Stau1-HA3. As in Figure 1D, except that Cos cells were transiently transfected with the Stau1-HA3 expression vector, pSport-Arf1 or
pSport-Arf1(3UTR), and phCMV-MUP. Notably, cells were transfected with only half as much pSport-Arf1(3UTR) relative to pSport-Arf1
in order to compensate for the difference in the level of product mRNA. Protein or RNA before and after IP was analyzed, respectively, using
Western blotting and-HA antibody (upper) or RT-PCR (lower). For all RT-PCR results, mRNA levels in two independently performed experiments
did not differ by more than 20%.
distalmost nucleotide of the Arf1 3UTR within pSport- tein revealed relative IP efficiencies (Figure 6B, upper).
RT-PCR of immunopurified RNA demonstrated thatArf1 (Figure 6A). Each of the resulting test plasmids was
transiently introduced into 293 cells together with the Stau1 binds between nucleotides 689 and 919 (Figure
6B, lower, where the first transcribed nucleotide of en-Stau-HA3 expression vector. Cell extract was prepared
2 days later, and a fraction was immunopurified using dogenous Arf1 mRNA is defined as 1). Notably, the small
amount of Stau1 binding that is detected using mRNAs-HA antibody. Western blotting of immunopurified pro-
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Figure 6. Stau1 Binds Within an230 nt Region of the Arf1 mRNA 3UTR, and This Region Reduces the Half-Life of Arf1 mRNA by a Mechanism
that Depends on Stau1 and Upf1
(A) Schematic representations of the various Arf1 mRNAs harboring deletions within the 3UTR. Numbering is relative to the first nucleotide
of endogenous Arf1 mRNA, which is defined as 1. The uppermost construct represents full-length mRNA.
(B) 293 cells were transfected with the Stau1-HA3 expression vector and the specified pSport-Arf1 test plasmid. Protein or RNA was analyzed
after IP using, respectively, Western blotting (upper) or RT-PCR and ethidium bromide staining (lower). The level of Arf1 mRNA from each
pSport test plasmid was similarly assessed before IP to control for variations in transfection efficiencies and RNA recovery.
(C) L cells were transfected with mouse (m)Stau1, mUpf1, mUpf2, or control siRNA. Two days later, cells were retransfected with the pfos-
Arf1-SBS test plasmid (upper left) and the phCMV-MUP reference plasmid in the absence of serum. Serum was added to 15% after an
additional 24 hr, and protein was purified from the cytoplasmic fraction for Western blotting (second from top, left and right). RNA was purified
from the nuclear fraction for RT-PCR analysis at the specified times (second from bottom, left and right). For each time point, the level of
pfos-Arf1-SBS mRNA was normalized to the level of MUP mRNA. Normalized levels were calculated as a percentage of the normalized level
of fos-Arf1-SBS mRNA at 30 min in the presence of each siRNA, which was defined as 100. Normalized levels represent the average of two
independently performed experiments that did not vary by more than 20%. They are plotted as a function of time after serum addition (bottom,
left and right).
that terminate at nucleotide 621 or 688 reflects our find- the 3UTR downstream of nucleotide 919 or upstream
of nucleotide 688, our finding that inserting the Stau1ing that Stau1 binds less efficiently to the coding region
than to the 3UTR (Figures 5D and 6B). While these data binding site (SBS, nucleotides 622–924) within FLuc
mRNA reduced FLuc mRNA abundance (Supplementaldo not rule out the possibility that Stau1 also binds within
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Figure S5A) corroborates that Stau1 indeed binds be- S6). Consistent with these conclusions, we provide evi-
dence that Upf1 is the last of the Upf proteins to functiontween nucleotides 689 and 919. We conclude that Stau1
in EJC-dependent NMD and that Upf3 and Upf3X func-binds to the 3UTR of Arf1 mRNA at a position that is
tion prior to Upf2 (Figure 4).predicted to reduce mRNA abundance.
We find that Stau1 plays no detectable role in theTo determine if Stau1 and Upf1 mediate a reduction
EJC-dependent NMD of Gl or GPx1 mRNA (Figure 2).in Arf1 mRNA half-life, the expression of Arf1 cDNA
This is despite the ability of Stau1 to interact with Ba-harboring the SBS in place of the full-length 3UTR was
rentsz (Macchi et al., 2003; Figure 1), which interactsdriven by the fos promoter (Figure 6C, upper). This pro-
directly with the EJC component eIF4AIII and specifi-moter is transiently inducible upon the addition of serum
cally associates with mRNAs containing an EJC in vitroto serum-deprived cells and thus provides a way to
(Chan et al., 2004; Degot et al., 2004; Palacios et al.,analyze mRNA half-life (Lejeune et al., 2003). L cells were
2004). However, neither Stau1 nor Barentsz was de-transfected with mouse (m)Stau1 siRNA, mUpf1 siRNA,
tected as a stable EJC component (Figure 1).or, as negative controls, mUpf2 siRNA or control siRNA
As a rule, a termination codon that resides more thanand, 2 days later, with the pfos-Arf1-SBS test plasmid
50–55 nt upstream of an exon-exon junction elicitsand the phCMV-MUP reference plasmid in the absence
NMD (Nagy and Maquat, 1998). Considering that an EJCof serum. One day later, serum was added, and protein
resides 20–25 nt upstream of an exon-exon junctionand RNA were purified from, respectively, cytoplasmic
(Le Hir et al., 2000a), it follows that a termination codonand nuclear fractions after 0, 30, 60, 90, and 120 min.
that resides more than 25 nt upstream of a Stau1Western blotting demonstrated that the levels of
binding site should elicit SMD. These two scenarios aremStau1, mUpf1, and mUpf2 were downregulated to, re-
exemplified for Arf1 mRNA, which harbors four exon-spectively, 21%, 18%, and 26% of normal (Figure 6C,
exon junctions and binds Stau1 67 nt downstream ofsecond from top, left and right). RT-PCR demonstrated
the normal termination codon (Figure 7). In theory, itthat downregulating mStau1 or mUpf1 increased the
may be possible for a termination codon to be situatedhalf-life of nucleus-associated fos-Arf1-SBS mRNA,
so that it elicits both EJC-independent SMD and EJC-whereas downregulating mUpf2 did not (Figure 6C, sec-
dependent NMD. In fact, our data indicate that this pos-ond from bottom, and bottom, left and right). These data
sibility exists for Arf1 mRNA, which is normally a productreveal that Stau1 together with Upf1 mediates the decay
of pre-mRNA splicing and binds Stau1 within its cod-of Arf1 mRNA, which we call Stau1-mediated mRNA
ing region.decay (SMD). The specificity of the SBS involvement in
We have found in two independently performed mi-SMD was evident with the finding that downregulating
croarray analyses that there are at least 22 293 cellmStau1 to 29% of normal also increased the half-life of
mRNAs in addition to Arf1 mRNA that bind Stau1 (Sup-fos-FLuc-SBS mRNA (Supplemental Figure S5B). Fur-
plemental Table S1). This suggests that SMD is usedthermore, downregulating mStau1 to a comparable level
by cells to coordinately regulate a battery of genes in(21% of normal) had no effect on the half-life of fos-
response to changes in the cellular abundance or spe-Arf1(3UTR) mRNA (Supplemental Figure S6). These
cific activity of Stau1, Upf1, or both (see below). If bind-data, like the steady-state data (Figures 4 and 5 and
ing is sufficiently downstream of the normal terminationSupplemental Figures S4 and S5A), indicate that the
codon, then these mRNAs should, like Arf1 mRNA, beSMD of Arf1 mRNA involves the Arf1 SBS, Stau1, and
natural targets of SMD by a mechanism that is EJCUpf1 but not detectably Upf2.
independent. For example, Stau1 also binds the 3UTR
of PAICS mRNA (and also elsewhere within PAICS
Discussion mRNA), and downregulating Stau1 increases PAICS
mRNA abundance 2-fold (Supplemental Figure S7).
In this communication, we describe a role for mamma- Natural substrates for SMD could arise when a termina-
lian Stau1 in a type of mRNA decay that involves the tion codon is generated by alternative splicing, which
NMD factor Upf1 but not an EJC. We demonstrate that has been proposed to occur one-third of the time (Hill-
Stau1 directly binds Upf1 (Figure 1). We also demon- man et al., 2004), provided that the termination codon
strate that tethering Stau1 downstream of a termination resides a sufficient distance upstream of a Stau1 binding
codon reduces mRNA abundance (Figure 3) by a mecha- site. Notably, there may be mRNAs that are more effi-
nism that appears to involve the termination codon (Sup- ciently targeted for SMD than those identified to date,
plemental Figure S2) and Upf1 but not detectably Upf2 i.e., that would have insufficient abundance to be de-
or Upf3X (Figure 4). As additional support for the impor- tected in a microarray analysis of Stau1 bound tran-
tance of a termination codon, downregulating Stau1 in- scripts (Supplemental Table S1). In fact, some of these
creased the level of Arf1 35Ter mRNA that derived from may be among the mRNAs that increase in abundance
cDNA (Y.K.K. and L.E.M., unpublished data), indicating when Upf1 is downregulated but not in accordance with
that 35Ter can elicit SMD via Stau1 binding to the 3UTR rules that pertain to NMD (Mendell et al., 2004).
as well as the coding region (Figure 5D). Furthermore, With regard to the possible regulation of SMD, Stau1
a cyclohexamide-mediated block in translation inhibited is ubiquitously expressed, but its level of expression
SMD (Y.K.K. and L.E.M., unpublished data). SMD is varies among tissues (Marion et al., 1999; Monshausen
shown to be physiologically relevant with the finding et al., 2001; Wickham et al., 1999). For example, Stau1
that Stau1 binds to an 230 nt region of the 3UTR of expression is upregulated following myogenic differenti-
Arf1 mRNA so as to recruit Upf1 independently of other ation and after denervation or treatment of muscle cells
Upf proteins and, as a consequence, reduce Arf1 mRNA with trophic factors (Belanger et al., 2003). Additionally,
differential splicing generates several Stau1 isoformshalf-life (Figures 5 and 6 and Supplemental Figures S3–
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Figure 7. Models for EJC-Dependent NMD
and EJC-Independent SMD of Arf1 mRNA in
Mammalian Cells
(A) Recruitment of Upf1 to one of the four
EJCs of Arf1 mRNA via Upf2 and Upf3/3X.
Within the nucleus, pre-mRNA splicing de-
posits an exon junction complex (EJC) of pro-
teins that is located 20–25 nucleotides up-
stream of each exon-exon junction. The EJC
includes the NMD factor Upf3 or Upf3X, each
of which binds Upf2, and Upf2 is thought to
subsequently bind Upf1. EJC-dependent
NMD occurs if translation terminates prema-
turely more than 50–55 nucleotides up-
stream of any exon-exon junction, which
would be20–25 nucleotide upstream of the
corresponding EJC (only the 3-most of which
is shown).
(B) Recruitment of Upf1 to the 3UTR of Arf1
mRNA via Stau1. Stau1, which binds the
3UTR of Arf1 mRNA, recruits Upf1 indepen-
dently of an EJC. Data suggest that SMD oc-
curs when translation terminates properly. By
analogy to EJC-dependent NMD, the Stau1
binding site would reside more than 20–25
nt downstream of the normal termination co-
don in order to elicit SMD.
that are not uniformly expressed among tissues. Stau1 Hrb27C inhibits the removal by nuclear splicing of intron
3 from P-element-encoded transposase pre-mRNA inalso contains several putative phosphorylation sites that
could regulate its function, and Stau1 has been shown Drosophila (Hammond et al., 1997; Siebel et al., 1994),
and it also binds directly to Drosophila gurken mRNAto interact with protein phosphatase-1 (Monshausen et
al., 2002). Therefore, the functions of Stau1 are likely to so as to regulate gurken mRNA cytoplasmic localization
and translation (Goodrich et al., 2004). As other exam-be modulated in different tissues according to the level
and nature of each expressed isoform and, possibly, ples, Barentsz and Y14, which are components of the
EJC (Degot et al., 2004; Kim et al., 2001; Lau et al., 2003;posttranslational modifications. Since Upf1 phosphory-
lation influences Upf1 function in NMD (Ohnishi et al., Palacios et al., 2004), are essential for EJC-dependent
NMD in mammalian cells (Ferraiuolo et al., 2004; Gehring2003; Pal et al., 2001), it is possible that Upf1 phosphory-
lation also regulates Upf1 function in SMD. et al., 2003; Palacios et al., 2004; Shibuya et al., 2004),
and they also function in localizing Drosophila oskarSeveral Stau1 bound mRNAs encode key regulatory
enzymes that control cell metabolism, proteins involved mRNA to the posterior pole of the oocyte (Hachet and
Ephrussi, 2001, 2004; Mohr et al., 2001; van Eeden etin organelle trafficking, or proteins involved in cell divi-
sion or the cell cycle or both (Supplemental Table S1). al., 2001).
In summary, our findings expand the role of Stau1 inArf1 is involved in protein trafficking, and it may modu-
late vesicle budding and uncoating within the Golgi ap- posttranscriptional gene control. Significant issues that
have been brought to light by our studies include whetherparatus. PAICS controls steps 6 and 7 of the purine
nucleotide biosynthetic pathway. Interestingly, the level the Stau1-mediated recruitment of Upf1 to mRNAs im-
pacts mammalian development, neuronal transmission,of PAICS mRNA varies with the cell cycle in synchro-
nized rat 3Y1 fibroblasts (Iwahana et al., 1995). At least or cellular growth control. It will also be important to
determine if Staufen and Upf1 interact in Drosophila soin theory, this variation may be controlled by SMD. From
these and other examples, it is conceivable that modula- as to elicit mRNA decay.
tion of Stau1, Upf1, or both may control the level of SMD
Experimental Proceduresin response to signal transduction or other regulatory
pathways.
Plasmid Constructions
In addition to its involvement in this type of mRNA Human UPF1 cDNA was inserted into pSos (Stratagene) for two-
decay, Stau1 is a component of mRNPs that are trans- hybrid analysis or pGEX-6p-1NdeI (Kielkopf and Burley, 2002) for
bacterial production of GST-Upf1. Human Stau1 cDNA was insertedported and localized within dendrites of mature hippo-
into pGEX-6p-1NdeI or pRSET B (Invitrogen) for bacterial produc-campal neurons (Kanai et al., 2004; Kiebler et al., 1999;
tion of GST-Upf1 or 6xHis-Stau1, respectively.Kohrmann et al., 1999; Krichevsky and Kosik, 2001; Mal-
A DNA fragment that encodes MS2 coat protein followed by anlardo et al., 2003; Ohashi et al., 2002). There are a number
HA tag or HA-Stau1 was inserted into pCI-neo (Promega) to generate
of RNP proteins that function in two distinct RNA meta- pMS2-HA or pMS2-HA-Stau1, respectively. pcFLuc-MS2bs was
bolic processes, one of which involves mRNA localiza- generated from pc-8bs (Lykke-Andersen et al., 2000) by replacing
-globin cDNA with FLuc cDNA. pcFLuc was generated fromtion coupled to translational control. As one example,
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pcFLuc-8bs by removing the MS2 binding sites. pRLuc was gener- RT-PCR
The levels of specific RNAs were quantitated using RT-PCR as de-ated from p2luc (Grentzmann et al., 1998) by precisely deleting
FLuc cDNA. scribed (Sun et al., 1998; Supplemental Data).
Full-length Arf1 cDNA was obtained by RT-PCR (Applied Biosys-
tems) using total HEK293-cell RNA and inserted into pSport -gal Acknowledgments
(Invitrogen) to generate pSport-Arf1. Deletions within the 3UTR of
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